Solid-phase synthesis and in vitro activity research of tumor-targeting cell-penetrating peptide.
- Author:
Ji-wen HE
1
;
Hua LI
;
Nan JIANG
;
Yan TAI
;
Qi ZHANG
;
Yang YANG
;
Gui-hua CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Cell Line, Tumor; Cell-Penetrating Peptides; chemical synthesis; pharmacology; Drug Delivery Systems; Drug Design; Humans; Liver Neoplasms; drug therapy; metabolism; pathology; Matrix Metalloproteinase 2; metabolism; Rhodamines; chemistry; Solid-Phase Synthesis Techniques
- From: Journal of Southern Medical University 2011;31(2):201-204
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo synthesize a tumor-targeting cell-penetrating peptide (CPP) and evaluate its biological activity and cytotoxicity in vitro.
METHODSWith fluorenylmethyloxycarbonyl (Fmoc) as the protective group of α-amino acid, the tumor-targeting CPP were synthesized with stepwise amino acid extension using solid-phase synthesis method. 5-carboxytetramethylrhodamine was added for fluorescence labeling in the presence of the coupling agents HATU and DMF. The purity of the CPP was measured by high-performance liquid chromatography and its molecular weight measured by mass spectrometry. Fluorescence microscope was used to assess the cell-penetrating activity?of the CPP in hepatocellular carcinoma cell lines SMMC-7721 and normal hepatocellular cell lines LO2. The growth activity of CPP-treated SMMC-7721 cells was measured by MTT assay.
RESULTSWith a purity of 96.05% and a relative molecular mass of 3504.9, the synthesized CPP showed no translocation activity in normal hepatocellular cell lines LO2, but showed strong ability to translocate into SMMC-7721 cells without affecting the biological activity of the cells.
CONCLUSIONUsing Fmoc solid-phase synthesis method, we have successfully synthesized the CPP with tumor-targeting activity.